1. Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells
   Karen A. Oliveira et al, 2017, Mol Neurobiol CrossRef
2. Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway
   Wei Zhou et al, 2017, Front. Mol. Neurosci. CrossRef
3. Quercetin blocks t-AUCB-induced autophagy by Hsp27 and Atg7 inhibition in glioblastoma cells in vitro
   Junyang Li et al, 2016, J Neurooncol CrossRef
4. Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness
   Qiuji Wu et al, 2017, Front. Immunol. CrossRef
5. Bioinformatic mining of kinase inhibitors that regulate autophagy through kinase signaling pathways
   YANG YANG et al, 2014 CrossRef
6. Gene expression profiling in myelodysplastic syndrome after SPARC overexpression associated with Ara-C
   QING NIAN et al, 2015 CrossRef
7. Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.
   Sabine Hombach-Klonisch et al, 2018, Pharmacol Ther CrossRef
8. Pine (Pinus morrisonicola Hayata) Needle Extracts Sensitize GBM8901 Human Glioblastoma Cells to Temozolomide by Downregulating Autophagy and O6-Methylguanine-DNA Methyltransferase Expression
   Chia-Leng Liao et al, 2014, J. Agric. Food Chem. CrossRef
9. Monitoring autophagic flux using p62/SQSTM1 based luciferase reporters in glioma cells
   Zhang Min et al, 2017, Experimental Cell Research CrossRef
10. Extract of Euryale ferox Salisb exerts antidepressant effects and regulates autophagy through the adenosine monophosphate-activated protein kinase-UNC-51-like kinase 1 pathway
    Zhiheng Huang et al, 2018, IUBMB Life CrossRef
11. Pro-survival autophagy and cancer cell resistance to therapy
    Chandan Kanta Das et al, 2018, Cancer Metastasis Rev CrossRef
12. UNC-51-like Kinase 1: From an Autophagic Initiator to Multifunctional Drug Target
    Lan Zhang et al, 2018, J. Med. Chem. CrossRef
13. Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
    Alessia Lo Dico et al, 2018, Front. Oncol. CrossRef
14. Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics
    Jurgen Kriel et al, 2018, Sci Rep CrossRef
15. Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy.
    Xinlei Yu et al, 2015, Autophagy CrossRef
16. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma
    Matthew A. Taylor et al, 2018, Apoptosis CrossRef
17. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.
    Shabierjiang Jiapaer et al, 2018, Neurol Med Chir (Tokyo) CrossRef
18. Multiple molecular pathways stimulating macroautophagy protect from alpha-synuclein-induced toxicity in human neurons
    Matthias Höllerhage et al, 2019, Neuropharmacology CrossRef
19. Autophagy: supporting cellular and organismal homeostasis by self-eating
    Eeva-Liisa Eskelinen, 2019, The International Journal of Biochemistry & Cell Biology CrossRef
20. In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin
    Qi Ni et al, 2019, Journal of Ethnopharmacology CrossRef
21. Glioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois'.
    Soha Jawhari et al, 2016, Cell Death Dis CrossRef
22. MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
    Michal Smida et al, 2016, Nat Commun CrossRef
23. Crocin induces anti-ischemia in middle cerebral artery occlusion rats and inhibits autophagy by regulating the mammalian target of rapamycin
    Zhiheng Huang et al, 2019, European Journal of Pharmacology CrossRef
24. KIM ‐1‐/ TIM ‐1‐mediated phagocytosis links ATG 5‐/ ULK 1‐dependent clearance of apoptotic cells to antigen presentation
    Craig R Brooks et al, 2015, EMBO J CrossRef
25. Recently Emerging Signaling Landscape of Ataxia-Telangiectasia Mutated (ATM) Kinase
    Ammad Ahmad Farooqi et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef
26. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells
    Fahim Atif et al, 2015, PLoS ONE CrossRef
27. Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis
    Anuradha Gupta et al, 2016, Advanced Drug Delivery Reviews CrossRef
28. RLIP76 Depletion Enhances Autophagic Flux in U251 Cells
    Chenran Zhang et al, 2017, Cell Mol Neurobiol CrossRef
29. ULK1 Can Suppress or Promote Tumor Growth Under Different Conditions
    Tian Mao et al, 2017 CrossRef
30. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
    Francesco Ciccarese et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
31. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide
    Laurence Booth et al, 2017, Oncotarget CrossRef
32. Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
    Silvia Valtorta et al, 2017, Oncotarget CrossRef
33. Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms
    Zatollah Asemi et al, 2020, Cell Mol Neurobiol CrossRef
34. Effect and molecular mechanism of mTOR inhibitor rapamycin on temozolomide‑induced autophagic death of U251 glioma cells
    Bing Li et al, 2017, Oncol Lett CrossRef
35. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways
    Ali Bagherian et al, 2020, J Mol Neurosci CrossRef
36. Next generation DNA sequencing of atypical choroid plexus papilloma of brain: Identification of novel mutations in a female patient by Ion Proton
    Mohiuddin Taher et al, 2019, Oncol Lett CrossRef
37. ATM loss disrupts the autophagy-lysosomal pathway
    Aifang Cheng et al, 2020, Autophagy CrossRef
38. Towards DNA-damage induced autophagy: A Boolean model of p53-induced cell fate mechanisms
    Shantanu Gupta et al, 2020, DNA Repair CrossRef
39. Autophagy Takes Center Stage as a Possible Cancer Hallmark.
    Jose G Alvarez-Meythaler et al, 2020, Front Oncol CrossRef
40. T-Type Cav3.1 Channels Mediate Progression and Chemotherapeutic Resistance in Glioblastoma
    Anna Visa et al, 2019, Cancer Res CrossRef
41. Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
    Yong Zheng et al, 2021, Cell Biosci CrossRef
42. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
    Manendra Singh Tomar et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
43. Icaritin alleviates docetaxel‐induced skin injury by suppressing reactive oxygen species via estrogen receptors
    Jie Zou et al, 2021, Thorac Cancer CrossRef
44. Repurposing autophagy regulators in brain tumors.
    Edgar Petrosyan et al, 2022, Int J Cancer CrossRef
45. XAF1 directs glioma response to temozolomide through apoptotic transition of autophagy by activation of ATM–AMPK signaling
    Min-Goo Lee et al, 2022 CrossRef
46. Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
    Juliana B Vilar et al, 2022, Cancers (Basel) CrossRef
47. Autophagy and beyond: Unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications
    Ling Zou et al, 2022, Acta Pharmaceutica Sinica B CrossRef
48. N3-Substituted Temozolomide Analogs Overcome Methylguanine-DNA Methyltransferase and Mismatch Repair Precipitating Apoptotic and Autophagic Cancer Cell Death
    Jihong Zhang et al, 2015, Oncology CrossRef
49. Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells In Vitro by Inhibiting Autophagy
    Zhihua Chen et al, 2022, Computational Intelligence and Neuroscience CrossRef
50. Fundamental signaling pathways for glioblastoma drug resistance and developing robust organoid models for drug discovery
    Athira Pratap et al, 2022, Organoid CrossRef
51. Quadra-Stable Dynamics of p53 and PTEN in the DNA Damage Response
    Shantanu Gupta et al, 2023, Cells CrossRef
52. The STAT3-Regulated Autophagy Pathway in Glioblastoma
    Ronald Nicholas Laribee et al, 2023, Pharmaceuticals CrossRef
53. Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
    Soumaya Rafii et al, 2023, Front. Oncol. CrossRef
54. Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells
    Wenbin Yuan et al, 2023, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
55. Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma
    Peng Zhang et al, 2023, Heliyon CrossRef
56. The mechanism of UNC-51-like kinase 1 and the applications of small molecule modulators in cancer treatment
    Dejuan Sun et al, 2024, European Journal of Medicinal Chemistry CrossRef
57. Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective
    Ting Wang et al, 2024, Cell Mol Biol Lett CrossRef
58. Unraveling the genetic and molecular landscape of sepsis and acute kidney injury: A comprehensive GWAS and machine learning approach
    Sha Yang et al, 2024, International Immunopharmacology CrossRef
59. Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment
    Zhumin Cao et al, 2024, Front. Immunol. CrossRef
60. Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo
    Daniel P. Radin et al, 2024, The Journal of Pharmacology and Experimental Therapeutics CrossRef